# Phio Pharmaceuticals Corp.: Form 10-K/A for the period ended Dec 31, 2021

- Company: [Phio Pharmaceuticals Corp.](/companies/phio.md) (CIK 1533040)
- Form: 10-K/A
- Filed: 2022-04-29
- Accepted by EDGAR: Apr 29, 2022, 16:45 ET
- Period: 2021-12-31
- Accession: 0001683168-22-003052
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1533040/000168316822003052/phio_i10ka1-123121.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1533040/000168316822003052/

## Sections

No standard item headings were found in this filing’s main document, so no sections were extracted. Read the original on sec.gov. https://www.sec.gov/Archives/edgar/data/1533040/000168316822003052/phio_i10ka1-123121.htm

Filed Apr 29, 2022.
Source: SEC EDGAR, the filing index for accession 0001683168-22-003052. Last ingested by Listed: Nov 12, 2026, 20:44 ET. No prices; not investment advice.
